Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1996
05/15/1996CN1122329A Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
05/14/1996US5516784 Anti-HIV (AIDS) agents
05/14/1996US5516756 Microbiocides
05/14/1996US5516682 Subtilin variant of enhanced stability and activity
05/14/1996US5516675 Separation of lactoperoxidase, secretory component and lactoferrin from milk or whey with a cation exchange resin
05/14/1996CA2008632C Method of inducing the production of cytokines
05/10/1996CA2162342A1 Intravenous solutions for a derivative of staurosporine
05/10/1996CA2162341A1 Pharmaceutical carriers
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013506A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996WO1996013502A1 Phenyloxazolidinone antimicrobials
05/09/1996WO1996013498A2 L-erythrosyl nucleosides
05/09/1996WO1996013273A1 Pharmaceutical compositions
05/09/1996WO1996013272A1 Aza cyclohexapeptide compounds
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996WO1996013247A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996CA2203920A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203767A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996CA2202920A1 Aza cyclohexapeptide compounds
05/08/1996EP0710667A2 Modified oligonucleotides, their preparation and their use
05/08/1996EP0710294A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis
05/08/1996EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710120A1 Recombinant swinepox virus
05/08/1996EP0423198B1 Antibodies specific towards hiv 1 gp 48
05/08/1996CN1122138A Foldback triplex-forming oligonucleotides
05/08/1996CN1122107A Antiviral powder, antiviral extract, and pharmaceutical preparation containing said powder and/or said extract
05/08/1996CN1121959A Recombinant infectious non-segmented negative strand RNA virus
05/08/1996CN1121919A 5-membered heteroaryl-oxazoli-dinones
05/07/1996US5514801 Cyclic sulfone containing retroviral protease inhibitors
05/07/1996US5514786 Compositions for inhibiting RNA activity
05/07/1996US5514778 Anti-picornaviral agents
05/07/1996US5514715 Amino cyclopentanecarboxylic acid, fungicide
05/07/1996US5514668 Crown ether attached to polysaccharide, demetallization, removal of viruses, ammonia, amines
05/07/1996US5514665 Especially for cystic fibrosis patients
05/07/1996US5514664 Antitumor chemotherapy
05/07/1996US5514662 Hiv infections
05/07/1996US5514661 Autoimmune disease treatment
05/07/1996US5514650 Pneumocystis fungicide
05/07/1996US5514649 Animal growth regulators; treating gramnegative and grampositive bacterial infections
05/07/1996US5514648 Fungicidally active compounds
05/07/1996US5514577 Oligonucleotide therapies for modulating the effects of herpes viruses
05/07/1996US5514383 Process for the preparation of tablets of derivatives of cephalosporanic acid by direct compression
05/07/1996US5514370 High dosage topical forms of collagenase
05/07/1996CA2075551C Treatment of periodontitis
05/07/1996CA1338310C Polycyclic peptide antibiotic and method for production thereof
05/05/1996CA2162075A1 Modified oligonucleotides, their preparation and their use
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996WO1996012808A1 Nucleic acid preparation for immunization and method for immunization using the same
05/02/1996WO1996012807A2 Hepatitis e virus antigens and uses therefor
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996WO1996012790A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012733A1 Major outer membrane protein cd of moraxella
05/02/1996WO1996012728A1 L-pyranosyl nucleosides
05/02/1996WO1996012727A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
05/02/1996WO1996012720A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
05/02/1996WO1996012497A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
05/02/1996WO1996012492A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012487A1 Combination method for acne treatment
05/02/1996WO1996012471A1 Novel and improved aminoglycoside formulation for aerosolization
05/02/1996WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996WO1996006103A3 α-D-PENTOFURANOSIDE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND THEIR USE
05/02/1996CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/02/1996CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996CA2199979A1 Combination method for acne treatment
05/01/1996EP0709082A2 Combinations of active ingredients based on wool wax acids and glycerides of saturated fatty acids efficient against impure skin, slight forms of acne as well as propionibacterium acnes
05/01/1996EP0708772A1 IMIDAZO [4,5-c]PYRIDIN-4-AMINES
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708763A1 Process for making hiv protease inhibitors
05/01/1996EP0708760A1 Cyclic hydrazine compounds
05/01/1996EP0708659A1 Hiv envelope polypeptides
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates
05/01/1996CN1121725A Immunoparticles bearing monoclonal anti-CD4 antibodies and utilisation thereof
05/01/1996CN1121724A Extraction of cell-bound protein from bordetella
05/01/1996CN1121721A Oligonucleotido alky phosphate and alky substituted phosphate
05/01/1996CN1121707A Unsaturate amino compounds for use as anticancer and antiprotozoic agent
05/01/1996CN1121683A Ionene polymers as microbicides
05/01/1996CN1031713C Process for preparing 9-purinyl phosphonic acid derivatives
05/01/1996CN1031710C Process for preparing quinoline carboxylic acid boric acid anhydride
04/1996
04/30/1996US5512588 Antiulcer agents
04/30/1996US5512553 Preventing or treating bacterial infections
04/30/1996US5512438 Inhibiting RNA expression by forming a pseudo-half-knot RNA at the target's
04/30/1996US5512289 Spermicidal anti-viral lubricant composition and method of using same
04/30/1996US5512269 Method of treating retained pulmonary secretions
04/30/1996US5512177 Narrow poly- and mono-dispersed anoinic oligomers, and their uses, formulations and process
04/30/1996CA2026278C Use of alkylphosphoric acid compounds for combatting psoriasis disorders
04/30/1996CA1338287C Hetrazepines and processes for preparing them
1 ... 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 ... 1798